Abstract
Carcinoma progression is associated with the loss of epithelial features, and the acquisition of mesenchymal characteristics and invasive properties by tumour cells. The loss of cell–cell contacts may be the first step of the epithelium mesenchyme transition (EMT) and involves the functional inactivation of the cell–cell adhesion molecule E-cadherin. Repression of E-cadherin expression by the transcription factor Snail is a central event during the loss of epithelial phenotype. Akt kinase activation is frequent in human carcinomas, and Akt regulates various cellular mechanisms including EMT. Here, we show that Snail activation and consequent repression of E-cadherin may depend on AKT-mediated nuclear factor-κB (NF-κB) activation, and that NF-κB induces Snail expression. Expression of the NF-κB subunit p65 is sufficient for EMT induction, validating this signalling module during EMT. NF-κB pathway activation is associated with tumour progression and metastasis of several human tumour types; E-cadherin acts as a metastasis suppressor protein. Thus, this signalling and transcriptional network linking AKT, NF-κB, Snail and E-cadherin during EMT is a potential target for antimetastatic therapeutics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
265,23 € per year
only 5,30 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Arenzana-Seisdedos F, Fernandez B, Dominguez I, Jacque JM, Thomas D, Diaz-Meco MT et al. (1993). Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. J Virol 67: 6596–6604.
Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM . (2005). Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial–mesenchymal transition. J Cell Biol 168: 29–33.
Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro S et al. (2004). Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23: 7345–7354.
Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J et al. (2000). The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84–89.
Bellacosa A, Chan TO, Ahmed NN, Datta K, Malstrom S, Stokoe D et al. (1998). Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17: 313–325.
Bellacosa A, Testa JR, Moore R, Larue L . (2004). A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities. Cancer Biol Ther 3: 268–275.
Berx G, Becker KF, Hofler H, van Roy F . (1998). Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12: 226–237.
Birchmeier W, Behrens J . (1994). Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198: 11–26.
Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A . (2003). The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116: 499–511.
Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY et al. (1995). Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol 15: 2809–2818.
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857–868.
Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL . (1999). Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene 18: 7423–7431.
Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT . (1999). Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 18: 3063–3070.
Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG et al. (2000). The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76–83.
Christofori G, Semb H . (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73–76.
Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H . (2007). NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711–724.
Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin Jr AS . (2000). Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19: 1123–1131.
Cohen P, Frame S . (2001). The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769–776.
Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E et al. (2001). The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267–1278.
De Craene B, Gilbert B, Stove C, Bruyneel E, van Roy F, Berx G . (2005). The transcription factor Snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 65: 6237–6244.
Du K, Montminy M . (1998). CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273: 32377–32379.
Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M et al. (2005). DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24: 2375–2385.
Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A, Schalken JA . (1997). Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 241: 453–458.
Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W et al. (2003). The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172–2178.
Gritz L, Davies J . (1983). Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 25: 179–188.
Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E et al. (2002). Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 277: 39209–39216.
Gustin JA, Korgaonkar CK, Pincheira R, Li Q, Donner DB . (2006). Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52. J Biol Chem 281: 16473–16481.
Hajra KM, Chen DY, Fearon ER . (2002). The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62: 1613–1618.
Hajra KM, Ji X, Fearon ER . (1999). Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 18: 7274–7279.
Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W . (1995). Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11: 475–484.
Hennig G, Lowrick O, Birchmeier W, Behrens J . (1996). Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 271: 595–602.
Huber MA, Kraut N, Beug H . (2005). Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548–558.
Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N et al. (2005). Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition. J Cell Biol 171: 1023–1034.
Ji X, Woodard AS, Rimm DL, Fearon ER . (1997). Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ 8: 773–778.
Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS et al. (2001). Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15: 1953–1962.
Larue L, Bellacosa A . (2005). Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24: 7443–7454.
Misra J, Schmitt W, Hwang D, Hsiao LL, Gullans S, Stephanopoulos G et al. (2002). Interactive exploration of microarray gene expression patterns in a reduced dimensional space. Genome Res 12: 1112–1120.
Morali OG, Delmas V, Moore R, Jeanney C, Thiery JP, Larue L . (2001). IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20: 4942–4950.
Morali O, Savagner P, Larue L . (2004). Epithelium–mesenchymal transitions are crucial morphogenetic events occurring during early development. In: Savagner P (ed). Rise and Fall of Epithelial Phenotype. Landes Biosciences Publisher: Georgetown, TX, USA, pp 12–28.
Nelles L, Van de Putte T, van Grunsven L, Huylebroeck D, Verschueren K . (2003). Organization of the mouse Zfhx1b gene encoding the two-handed zinc finger repressor Smad-interacting protein-1. Genomics 82: 460–469.
Nieto MA, Bennett MF, Sargent MG, Wilkinson DG . (1992). Cloning and developmental expression of Sna, a murine homologue of the Drosophila Snail gene. Development 116: 227–237.
Orlowski RZ, Baldwin Jr AS . (2002). NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8: 385–389.
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB . (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82–85.
Park BK, Zeng X, Glazer RI . (2001). Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res 61: 7647–7653.
Peinado H, Portillo F, Cano A . (2004). Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48: 365–375.
Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA et al. (2001). A new role for E12/E47 in the repression of E-cadherin expression and epithelial–mesenchymal transitions. J Biol Chem 276: 27424–27431.
Remacle JE, Kraft H, Lerchner W, Wuytens G, Collart C, Verschueren K et al. (1999). New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 18: 5073–5084.
Risinger JI, Berchuck A, Kohler MF, Boyd J . (1994). Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7: 98–102.
Rodrigo I, Cato AC, Cano A . (1999). Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element. Exp Cell Res 248: 358–371.
Rodriguez MS, Wright J, Thompson J, Thomas D, Baleux F, Virelizier JL et al. (1996). Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene 12: 2425–2435.
Schmid JA, Birbach A, Hofer-Warbinek R, Pengg M, Burner U, Furtmuller PG et al. (2000). Dynamics of NF kappa B and Ikappa Balpha studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNa by fluorescence resonance energy transfer. J Biol Chem 275: 17035–17042.
Stoyanova R, Clapper ML, Bellacosa A, Henske EP, Testa JR, Ross EA et al. (2004a). Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol Ther 3: 1313–1321.
Stoyanova R, Upson JJ, Patriotis C, Ross EA, Henske EP, Datta K et al. (2004b). Use of RNA amplification in the optimal characterization of global gene expression using cDNA microarrays. J Cell Physiol 201: 359–365.
Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM et al. (2000). E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569–573.
Tang ED, Nunez G, Barr FG, Guan KL . (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274: 16741–16746.
Testa JR, Bellacosa A . (2001). AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98: 10983–10985.
Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT et al. (2000). Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis 18: 423–428.
Thiery JP . (2002). Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442–454.
Van de Putte T, Maruhashi M, Francis A, Nelles L, Kondoh H, Huylebroeck D et al. (2003). Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. Am J Hum Genet 72: 465–470.
Viatour P, Merville MP, Bours V, Chariot A . (2005). Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30: 43–52.
Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, van Roy F . (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107–119.
Wang HD, Ren J, Zhang L . (2004). CDH1 germline mutation in hereditary gastric carcinoma. World J Gastroenterol 10: 3088–3093.
Wu JT, Kral JG . (2005). The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res 123: 158–169.
Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927–939.
Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S . (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92: 7416–7419.
Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M et al. (2004). Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial–mesenchymal transition. Nat Cell Biol 6: 931–940.
Acknowledgements
We are grateful to John Burch (FCCC, Philadelphia, USA) and Danny Huylebroeck (University of Leuven, Laboratory of Molecular Biology (Celgen) for their constructive comments. We thank Manijeh Pasdar (U. Alberta, Edmonton, Canada) for the desmoplakin antibody, Robert Weil (Institut Pasteur) for YFP-p65 and all members of the GDM lab. SJ was supported by Ministère de la Recherche, Ligue Contre le Cancer (Comité de l'Essonne) and Société Française du Cancer. IP was supported by an Institut Curie fellowship and ARC. LL holds an INSERM position. This work was supported by the Ligue Nationale Contre le Cancer (Equipe Labellisée).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Julien, S., Puig, I., Caretti, E. et al. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26, 7445–7456 (2007). https://doi.org/10.1038/sj.onc.1210546
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210546
Keywords
This article is cited by
-
Role of αENaC in root resorption of adjacent teeth due to entirely impacted mandibular third molars
BMC Oral Health (2024)
-
RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression
Oncogene (2024)
-
circPTEN1, a circular RNA generated from PTEN, suppresses cancer progression through inhibition of TGF-β/Smad signaling
Molecular Cancer (2022)
-
Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation
BMC Cancer (2022)
-
Breast cancer circulating tumor cells with mesenchymal features—an unreachable target?
Cellular and Molecular Life Sciences (2022)